Neighborhood Poverty and Pollution Linked to Higher Breast Cancer Risks
Living near Superfund sites can significantly elevate the risk of developing metastatic and triple-negative breast cancer, according to research from Sylvester Comprehensive…
Practical wellness advice, breakthrough studies and public-health alerts explained by medical professionals.
Living near Superfund sites can significantly elevate the risk of developing metastatic and triple-negative breast cancer, according to research from Sylvester Comprehensive…
Following a strict Pritikin health lifestyle alongside statin medications can reduce cholesterol by an additional 19% in just three weeks, according to research cited by health…
NHS doctors report a sharp 36% rise in children and young people attending emergency departments in England for mental health crises between 2019 and 2025, with primary…
Researchers exploring Rett syndrome have uncovered a new mechanical driver behind its hallmark breathing abnormalities, identifying peripheral chemoreceptors as a key culprit.
Congo’s unprecedented Ebola outbreak has surpassed 3,000 deaths out of more than 6,100 confirmed cases, according to government data released on Wednesday.
A flesh-eating parasitic fly known as the New World screwworm has been detected in a sheep in Coahuila, Mexico, just 31 miles from the U.S.
Britain announced on September 1, 2026, that it will provide more than £50 million ($67.56 million) in new funding to contain an Ebola outbreak in the Democratic Republic of Congo.
Broadcaster Jon Snow and other high-profile figures are calling on the UK government to implement a bold and ambitious strategy to reduce wait times for accurate dementia…
A North Carolina teenager has died after contracting Naegleria fowleri, a rare and often fatal brain-eating amoeba found in warm freshwater, according to the North Carolina…
A response-tailored antibiotic strategy reduced the duration of treatment by approximately one-third for patients with left-sided infective endocarditis without compromising…
University of Utah researchers have identified a protein, EFHD1, that appears to drive metabolic liver disease by triggering an out-of-place antiviral immune response.
The developments aim to bridge the gap between massive real-world datasets and the simplified models required for scientific discovery and drug development.